Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1855 1
1858 1
1859 1
1860 1
1861 1
1870 1
1890 1
1893 1
1895 1
1899 2
1900 2
1901 1
1903 1
1908 2
1911 1
1913 1
1915 6
1916 4
1921 1
1922 2
1923 2
1924 4
1925 2
1926 5
1927 2
1929 1
1930 1
1931 1
1932 5
1933 2
1935 2
1936 1
1938 2
1940 1
1942 1
1943 1
1944 1
1945 16
1946 121
1947 189
1948 199
1949 180
1950 171
1951 209
1952 245
1953 208
1954 239
1955 227
1956 271
1957 247
1958 306
1959 240
1960 194
1961 187
1962 171
1963 417
1964 573
1965 399
1966 375
1967 340
1968 380
1969 415
1970 416
1971 500
1972 548
1973 537
1974 561
1975 912
1976 993
1977 860
1978 946
1979 1089
1980 1353
1981 1355
1982 1404
1983 1557
1984 1777
1985 1891
1986 2136
1987 2355
1988 2766
1989 3208
1990 3493
1991 3629
1992 3846
1993 4241
1994 4407
1995 4707
1996 4935
1997 5287
1998 5550
1999 5920
2000 6381
2001 6617
2002 6924
2003 7748
2004 8821
2005 17538
2006 21598
2007 23184
2008 24581
2009 25304
2010 28141
2011 31190
2012 32943
2013 35265
2014 39040
2015 41377
2016 35848
2017 33549
2018 42120
2019 44496
2020 49064
2021 53033
2022 49064
2023 44899
2024 33914
2025 564

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

729,266 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy and Prevention of Pancreatic Cancer.
Morrison AH, Byrne KT, Vonderheide RH. Morrison AH, et al. Trends Cancer. 2018 Jun;4(6):418-428. doi: 10.1016/j.trecan.2018.04.001. Epub 2018 Apr 30. Trends Cancer. 2018. PMID: 29860986 Free PMC article. Review.
Pancreatic cancer is the third-leading cause of cancer mortality in the USA, recently surpassing breast cancer. A key component of pancreatic cancer's lethality is its acquired immune privilege, which is driven by an immunosuppressive microenvir …
Pancreatic cancer is the third-leading cause of cancer mortality in the USA, recently surpassing breast cancer. A key c …
N-acetylgalactosaminyltransferases in cancer.
Hussain MR, Hoessli DC, Fang M. Hussain MR, et al. Oncotarget. 2016 Aug 16;7(33):54067-54081. doi: 10.18632/oncotarget.10042. Oncotarget. 2016. PMID: 27322213 Free PMC article. Review.
Aberrant mucin-type O-glycosylation by glycosyltransferases is a well-described hallmark of many cancers and is also associated with additional non-cancerous developmental and metabolic disorders. The current review focuses on N-acetylgalactosaminyltransferas …
Aberrant mucin-type O-glycosylation by glycosyltransferases is a well-described hallmark of many cancers and is also associated with …
Unexpected guests in the tumor microenvironment: microbiome in cancer.
Wong-Rolle A, Wei HK, Zhao C, Jin C. Wong-Rolle A, et al. Protein Cell. 2021 May;12(5):426-435. doi: 10.1007/s13238-020-00813-8. Epub 2020 Dec 9. Protein Cell. 2021. PMID: 33296049 Free PMC article. Review.
Although intestinal microbiome have been established as an important biomarker and regulator of cancer development and therapeutic response, less is known about the role of microbiome at other body sites in cancer. Emerging evidence has revealed that the local micro …
Although intestinal microbiome have been established as an important biomarker and regulator of cancer development and therapeutic re …
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E, Fernández-Medarde A. Pérez-Herrero E, et al. Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Free article. Review.
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases. ...While surgery and radiotherapy are the primary treatment used for local and non-metastatic cancers, anti-cancer drugs (chemotherapy, hormone and biological therapies) …
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases. ...While surgery and radiotherapy are the pr …
Metabolic adaptation in hypoxia and cancer.
Paredes F, Williams HC, San Martin A. Paredes F, et al. Cancer Lett. 2021 Apr 1;502:133-142. doi: 10.1016/j.canlet.2020.12.020. Epub 2021 Jan 11. Cancer Lett. 2021. PMID: 33444690 Free PMC article. Review.
In this review, we highlight the role of the most important metabolic intermediaries that are at the center of cancer's biology, and in particular, the participation of these metabolites in HIF1alpha retrograde signaling during the establishment of pseudohypoxia. Fi …
In this review, we highlight the role of the most important metabolic intermediaries that are at the center of cancer's biolog …
PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?
Jarrold J, Davies CC. Jarrold J, et al. Trends Mol Med. 2019 Nov;25(11):993-1009. doi: 10.1016/j.molmed.2019.05.007. Epub 2019 Jun 20. Trends Mol Med. 2019. PMID: 31230909 Review.
If the writing, reading, and removal of modifications are not controlled, cancer can develop. Arginine methylation is an understudied modification that is increasingly associated with cancer progression. ...In this review we focus on advances made regarding the role …
If the writing, reading, and removal of modifications are not controlled, cancer can develop. Arginine methylation is an understudied …
Metabolic Codependencies in the Tumor Microenvironment.
Dey P, Kimmelman AC, DePinho RA. Dey P, et al. Cancer Discov. 2021 May;11(5):1067-1081. doi: 10.1158/2159-8290.CD-20-1211. Epub 2021 Jan 27. Cancer Discov. 2021. PMID: 33504580 Free PMC article. Review.
Metabolic reprogramming enables cancer cell growth, proliferation, and survival. This reprogramming is driven by the combined actions of oncogenic alterations in cancer cells and host cell factors acting on cancer cells in the tumor microenvironment. ...There …
Metabolic reprogramming enables cancer cell growth, proliferation, and survival. This reprogramming is driven by the combined actions …
How the ageing microenvironment influences tumour progression.
Fane M, Weeraratna AT. Fane M, et al. Nat Rev Cancer. 2020 Feb;20(2):89-106. doi: 10.1038/s41568-019-0222-9. Epub 2019 Dec 13. Nat Rev Cancer. 2020. PMID: 31836838 Free PMC article. Review.
Most cancers arise in individuals over the age of 60. As the world population is living longer and reaching older ages, cancer is becoming a substantial public health problem. ...Overall, the intention of this Review is to provide an overview of the interplay that o …
Most cancers arise in individuals over the age of 60. As the world population is living longer and reaching older ages, cancer …
Integrated Proteomic and N-Glycoproteomic Analyses of Human Breast Cancer.
Wang Z, Liu H, Yan Y, Yang X, Zhang Y, Wu L. Wang Z, et al. J Proteome Res. 2020 Aug 7;19(8):3499-3509. doi: 10.1021/acs.jproteome.0c00311. Epub 2020 Jun 16. J Proteome Res. 2020. PMID: 32543193
Breast cancer is one of the most common cancers in women worldwide. In the past decades, many advances have been made in understanding and treating breast cancer. However, due to the highly heterogeneous nature of this disease, a precise characterization of b …
Breast cancer is one of the most common cancers in women worldwide. In the past decades, many advances have been made in under …
Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Wickström M, Larsson R, Nygren P, Gullbo J. Wickström M, et al. Cancer Sci. 2011 Mar;102(3):501-8. doi: 10.1111/j.1349-7006.2010.01826.x. Epub 2011 Jan 30. Cancer Sci. 2011. PMID: 21205077 Free PMC article. Review.
The enzyme aminopeptidase N (APN, also known as CD13) is a Zn(2+) dependent membrane-bound ectopeptidase that degrades preferentially proteins and peptides with a N-terminal neutral amino acid. Aminopeptidase N has been associated with the growth of different …
The enzyme aminopeptidase N (APN, also known as CD13) is a Zn(2+) dependent membrane-bound ectopeptidase that degrades preferentially …
729,266 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "cancer n"